Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study
Matteo Bianco,
Alessandra Narcisi,
Luciano Ibba,
Mario Valenti,
Sara Di Giulio,
Francesco D'Oria,
Costanza Falcidia,
Giulio Foggi,
Antonio Costanzo,
Luigi Gargiulo International Journal of Dermatology
· Wiley
· 2026-11-12
· DOI: 10.1111/ijd.70789
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Matteo Bianco, Alessandra Narcisi, Luciano Ibba, Mario Valenti, Sara Di Giulio, Francesco D'Oria et al. Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study. // International Journal of Dermatology. – 2026. – DOI: 10.1111/ijd.70789. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ijd.70789?af=R
Matteo Bianco, Alessandra Narcisi, Luciano Ibba, Mario Valenti, Sara Di Giulio, Francesco D'Oria, Costanza Falcidia, Giulio Foggi, Antonio Costanzo, & Luigi Gargiulo (2026). Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study. International Journal of Dermatology. https://doi.org/10.1111/ijd.70789
Matteo Bianco, et al. “Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study.” International Journal of Dermatology, 2026. doi:10.1111/ijd.70789.
@article{Bianco2026,
title = {Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study},
author = {Bianco, Matteo and Narcisi, Alessandra and Ibba, Luciano and Valenti, Mario and Giulio, Sara Di and D'Oria, Francesco and Falcidia, Costanza and Foggi, Giulio and Costanzo, Antonio and Gargiulo, Luigi},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70789},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ijd.70789?af=R}
}